Concern over health-cost implications of medical IPOs

There seems to be more and more health companies, involving health professionals and private clinics, launching initial public offerings (IPOs).

While it is important to raise funds to expand and buy the latest equipment so that patients get the best possible treatment, there is also the question of conflict of interest and accountability to shareholders in terms of profits and dividends.

Will this result in higher charges? Will there be more mergers and acquisitions, and some kind of monopolistic practices arising out of these IPOs?

Lawrence Law Cher Khiam

A version of this article appeared in the print edition of The Straits Times on November 01, 2016, with the headline 'Concern over health-cost implications of medical IPOs'. Print Edition | Subscribe